← FDA Drug Approvals (Drugs@FDA)

BENDAMUSTINE HYDROCHLORIDE

NDA · New Drug Application · Sponsor: HOSPIRA · Approved 2022-12-15

Drug application

FDA Application #

NDA211530

Application type

New Drug Application

Brand name

BENDAMUSTINE HYDROCHLORIDE

Generic name

Bendamustine Hydrochloride

Active ingredients

BENDAMUSTINE HYDROCHLORIDE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Discontinued

Sponsor

HOSPIRA

First approval

2022-12-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown